GL1X · GenesisL1 explorer

MolNFT v1 · #39032 · protein

The structure of DPP4 in complex with an oxadiazole inhibitor

2HHA · Hypothetical protein DPP4: “The structure of DPP4 in complex with an oxadiazole inhibitor”. X-ray diffraction, 4 ligands (3TP, NAG, NDG), 17 pockets (best druggability 0.75). MolNFT v1 #39032 on GenesisL1: 3D structure, binding…

PDB
2HHA
Type
protein
Length
1,456 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hypothetical protein DPP4
EC
3.4.14.5
UniProt
Q53TN1
Ligands
3TP, NAG, NDG, NA
Pockets
17 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 18% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHypothetical protein DPP4 (EC 3.4.14.5)protein72818% helix, 37% strandQ53TN1

Ligands and binding sites

  • 3TP · (2S,3S)-3-{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-oxo-1-pyrrolidin-1-ylbutan-2-amine · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 22 copies · chains A, B
  • NDG · 2-acetamido-2-deoxy-alpha-D-glucopyranose · sugar · 2 copies · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

17 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1710.750.9822empty
28380.700.76993TP
37350.690.76953TP
42230.530.7731empty
52350.510.7633empty

Interfaces

1 interface between chains.

  • A–B · 2299 Ų buried · 43 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 15 glycan, 10 disulfide (N-glycosylation, disulfide).

Compared structures

  • 2HHA · The structure of DPP4 in complex with an oxadiazole inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.